Skip to main content
. 2018 Jun 29;12:430. doi: 10.3389/fnins.2018.00430

FIGURE 2.

FIGURE 2

The concentrations of Gal-3 in serum (ng/mL) of AD patients and healthy controls. AD patients showed enhanced Gal-3 concentrations in serum as compared to the healthy controls (AD vs. healthy controls [mean ± SD] 11.19 ± 3.67 vs. 8.76 ± 3.03 ng/mL; P = 0.022).